Health
Gout drug could reduce Covid hospital stays, new research finds – The Guardian
Colchicine also found to reduce need for extra oxygen and has potential to be used in outpatient settings
A cheap drug normally used to treat gout has been found to have the potential to significantly reduce hospital stays among Covid-19 patients and the need for extra oxygen.
The results of new research into colchicine conducted in Brazil come after an international trial published on Wednesday found that it reduced hospitalisations and deaths among Covid-19 patients by more than 20%.
Colchicine, which is used to treat rheumatic diseases, was hailed by researchers as having the potential to be the…
-
Noosa News24 hours agoWhere, when and why? Everything you need to know about Sunday’s pro-Palestine protest march in Brisbane
-
General16 hours agoAlbanese government to freeze construction code until 2029, fast-track housing approvals
-
General20 hours agoIndia to defend ‘red lines’ as fresh tariffs loom
-
Noosa News22 hours agoDance Nation shows the messy truth of adolescent dance comps